• Explore /
  • Poster
  • / Adjuvant gemcitabine for high-risk breast cancer (BC) patients: Final survival results of the randomized phase III SUCCESS-A study.

Adjuvant gemcitabine for high-risk breast cancer (BC) patients: Final survival results of the randomized phase III SUCCESS-A study.

Abstract Poster

Authors

null

Wolfgang Janni

Department of Gynecology and Obstetrics, University of Ulm, Ulm, Germany

Wolfgang Janni , Andreas Schneeweiss , Lothar Haeberle , Peter A. Fasching , Harald Leo Sommer , Mahdi Rezai , Joern Hilfrich , Hans Tesch , Georg Heinrich , Helmut Forstbauer , Thomas W. P. Friedl , Fabienne Schochter , Susanne Albrecht , Bernadette Jaeger , Julia Kathrin Jueckstock , Klaus Friese , Werner Lichtenegger , Matthias W. Beckmann , Brigitte Kathrin Rack

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Cytotoxic Chemotherapy

Clinical Trial Registration Number

2005-000490-21

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 1010)

DOI

10.1200/jco.2014.32.15_suppl.1010

Abstract #

1010

Poster Bd #

2

Abstract Disclosures

Similar Posters

First Author: Frederik Marme

First Author: Dimitrios Mavroudis

First Author: S. Loi

First Author: Joon Oh Park